Baillie Gifford & Co
CLOV icon

Baillie Gifford & Co’s Clover Health Investments CLOV Stock Holding History

Baillie Gifford & Co’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,645,503
Closed -$2.46M – 459
2022
Q4 		$2.46M Hold
2,645,503
– – ﹤0.01% 258
2022
Q3 		$4.5M Hold
2,645,503
– – ﹤0.01% 240
2022
Q2 		$5.66M Sell
2,645,503
-5,142,177
-66% -$13.7M 0.01% 229
2022
Q1 		$27.6M Hold
7,787,680
– – 0.02% 195
2021
Q4 		$29M Buy
7,787,680
+2,645,503
+51% +$16.2M 0.02% 206
2021
Q3 		$38M Hold
5,142,177
– – 0.02% 201
2021
Q2 		$68.5M Hold
5,142,177
– – 0.03% 168
2021
Q1 		$38.9M Buy
+5,142,177
New +$58M 0.02% 197

Other funds holding CLOV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return

Baillie Gifford & Co's CLOV Position: Q1 2023 in Review

Baillie Gifford & Co sold out of Clover Health Investments (CLOV) in Q1 2023, closing a stake of 2,645,503 shares — an estimated $2.46M sold.

Baillie Gifford & Co first reported a position in CLOV in Q1 2021 and held it in 8 quarters. The position peaked at $68.5M in Q2 2021. 157 funds tracked by Wall St. Rank hold CLOV as of Q1 2023.

  • Baillie Gifford & Co reported no remaining Clover Health Investments position as of Q1 2023 after selling out during the quarter.
  • Baillie Gifford & Co sold 2,645,503 Clover Health Investments shares in Q1 2023, an estimated $2.46M.
  • Baillie Gifford & Co first reported a position in Clover Health Investments in Q1 2021 and held it in 8 quarters.
  • Baillie Gifford & Co's Clover Health Investments position peaked at $68.5M in Q2 2021.
  • 157 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2023.

Based on Baillie Gifford & Co's 13F filing for Q1 2023, filed 3 May 2023.